Search

Embecta Corp

Gesloten

SectorGezondheidszorg

5.18 0.97

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

5.07

Max

5.28

Belangrijke statistieken

By Trading Economics

Inkomsten

25M

21M

Verkoop

50M

272M

K/W

Sectorgemiddelde

3.565

56.432

EPS

0.56

Dividendrendement

9.31

Winstmarge

7.766

Werknemers

1,850

EBITDA

17M

62M

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

9.31%

2.27%

Volgende Winsten

24 nov 2026

Volgende dividenddatum

17 dec 2026

Volgende Ex Dividend datum

4 dec 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

76M

297M

Vorige openingsprijs

4.21

Vorige sluitingsprijs

5.18

Nieuwssentiment

By Acuity

29%

71%

54 / 339 Rangschikking in Healthcare

Embecta Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 sep 2026, 20:10 UTC

Embecta Corp is advancing amid a positive market environment, though it remains below its 20-day moving average and near the lower end of its one-month range.

15 sep 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, contributing to a decline in shares amid broader market pressures.

14 sep 2026, 20:04 UTC

Embecta Corp shares are higher today, rebounding from an early dip without specific news to explain the movement. Broader market concerns include rising crude oil prices.

11 sep 2026, 19:16 UTC

Embecta Corp shares are higher amid U.S. Consumer Price Index data, which showed inflation at 3.4% annually, aligning with forecasts.

10 sep 2026, 21:31 UTC

Embecta Corp shares are higher in after-market trading, continuing an upward move since Thursday's close, despite being below its 20-day moving average.

9 sep 2026, 20:02 UTC

Embecta Corp shares are lower today, continuing a decline since Tuesday's close. The stock peaked earlier in the session before reversing sharply.

8 sep 2026, 20:02 UTC

News

Embecta Corp shares are lower as an investigation raises governance concerns among shareholders. Investors are assessing potential implications of the inquiry.

3 sep 2026, 19:36 UTC

Embecta Corp shares are higher as market sentiment improves amid easing interest rate concerns and declining Treasury yields.

2 sep 2026, 23:36 UTC

Embecta Corp. shares are higher in after-market hours, reflecting broader market trends amid ADP's report of weak private sector job growth in August.

1 sep 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified to explain the decline amid broader market concerns over rising crude oil prices.

31 aug 2026, 20:07 UTC

Embecta Corp shares are higher today, trading near the upper end of their one-month range and above the 20-day moving average.

28 aug 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified. The stock has shown strong performance over the past month.

27 aug 2026, 20:07 UTC

Event
News

Bronstein, Gewirtz & Grossman, LLC is investigating Embecta Corp for potential corporate wrongdoing. Shares are trading roughly flat following the company's recent $0.01 dividend.

26 aug 2026, 19:36 UTC

Embecta Corp's shares are lower today, continuing a downward trend since Tuesday. Economic data shows persistent inflation, impacting market sentiment.

25 aug 2026, 19:16 UTC

News

Embecta Corp. shares decline amid an announced investigation into potential corporate wrongdoing by Bronstein, Gewirtz & Grossman, LLC. Shares pulled back from earlier session highs.

24 aug 2026, 20:02 UTC

Embecta Corp's shares are lower amid broader market declines, reflecting ongoing geopolitical concerns. No specific company news was identified to explain the movement.

21 aug 2026, 23:02 UTC

Embecta Corp shares are lower in after-market hours, reflecting a decline since Friday's close amid broader market volatility linked to inflation concerns.

20 aug 2026, 19:41 UTC

Embecta Corp shares are higher during Thursday's session, despite an earlier pullback. No specific news was identified to explain the price movement.

19 aug 2026, 23:01 UTC

Embecta Corp shares are lower in after-market trading, having dipped by as much as -1.85% earlier. No specific news was identified for the movement.

18 aug 2026, 19:16 UTC

Embecta Corp's shares are higher during Tuesday's session, reflecting a modest increase since Monday's close amid rising Treasury yields and inflation concerns.

17 aug 2026, 23:41 UTC

Embecta Corp shares are higher in after-market trading, recovering from a recent low and remaining above their 20-day moving average. No specific news was identified.

15 aug 2026, 00:01 UTC

News

Embecta Corp shares are lower in after-market trading amid two class action lawsuits alleging securities fraud and a significant revenue decline.

14 aug 2026, 23:21 UTC

News

Embecta Corp shares are lower in after-market hours amid negative sentiment from two class action lawsuits alleging securities fraud and disappointing second-quarter guidance.

13 aug 2026, 23:01 UTC

Embecta Corp shares are higher in after-market trading, reflecting strong gains since Thursday's close and trading above its 20-day moving average.

12 aug 2026, 19:02 UTC

News

Embecta Corp shares are trading lower amid a class action lawsuit alleging securities fraud, following a significant revenue decline and ongoing scrutiny of financial performance.

11 aug 2026, 22:01 UTC

Embecta Corp shares are higher in after-market hours, continuing recent gains. The stock remains significantly above its 20-day moving average.

10 aug 2026, 23:21 UTC

News

Embecta Corp shares are lower in after-market trading amid a securities class action reminder regarding alleged misleading fiscal guidance.

7 aug 2026, 23:31 UTC

Embecta Corp is higher in after-market trading, reflecting positive momentum amid broader market strength and significant gains in major tech stocks.

6 aug 2026, 23:42 UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

5 aug 2026, 22:36 UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

Peer Vergelijking

Prijswijziging

Embecta Corp Prognose

Beoordelingsconsensus

By TipRanks

Sell

1 ratings

0

Buy

0

Hold

1

Sell

Sentiment

By Acuity

54 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat